Stigma Grow

Data Snapshot: May 04, 2024
Stigma Grow Cannabis Brand Logo
$100K+

Apr-2024

Sales

Decline

Trend

6-Month

15

Product Count

SKUs

Stigma Grow

Overview

Stigma Grow is a pioneering Alberta-based company, specializing in the cultivation of top-tier cannabis and the extraction of high-terpene cannabis extracts. As a wholly owned subsidiary of the Canadian cannabis company, CanadaBis Capital, it strives to offer consumers highly potent and quality-driven cannabis products. Recognised in the "Green Rush" of the cannabis industry, Stigma Grow stands out for its innovative approach to cannabis cultivation and extraction techniques, highlighting a global future perspective on cannabis as a potentially mainstream pain medicine.
Markets

Stigma Grow Locations

Product Trends

Stigma Grow Categories

Stigma Grow Sales

Market Insights Snapshot

Stigma Grow Historical Sales by Category

In the competitive cannabis market, Stigma Grow has shown notable performance across different categories and provinces, with a particularly strong presence in the Capsules category. In Alberta, Stigma Grow maintained the top position in the Capsules category from January to April 2024, despite a gradual decline in sales from 280,794 in January to 190,894 in April. This consistent ranking indicates a solid demand for their Capsules in Alberta. Conversely, their performance in the Concentrates category within the same province shows stability in ranking (16th to 15th from January to April) but doesn't capture a leadership position, suggesting room for growth or a focused strategy on their stronger categories.

Expanding the analysis to other provinces, Stigma Grow's performance in British Columbia and Ontario offers a mixed picture. In British Columbia, the brand saw a positive trend in the Concentrates category, climbing from 29th in January to 17th in April, alongside a slight decrease in the Capsules category from 6th to 7th. This upward trajectory in Concentrates suggests growing consumer interest or improved market strategies in British Columbia. Ontario presents a challenging landscape for Stigma Grow, with the brand entering the Concentrates category at 57th position in April, indicating significant room for improvement. However, their Capsules category performance remains strong, consistently ranking within the top 10, which underscores the brand's potential to leverage its strengths in specific categories and provinces for broader market penetration.

Apr-2024 Rank
Capsules
Concentrates
1
15
7
17
9
57
Stigma Grow

Competitive Landscape

In the competitive landscape of the cannabis capsule category in Alberta, Stigma Grow has maintained a leading position, consistently ranking 1st from January to April 2024. This dominance is underscored by its sales figures, which, despite a downward trend, have kept it ahead of its closest competitors, Glacial Gold and Dosecann. Glacial Gold, showing a notable upward movement in rank from 4th to 2nd place during the same period, has seen a significant increase in sales, indicating a growing challenge to Stigma Grow's market share. Conversely, Dosecann experienced fluctuations in both rank and sales, dropping from 2nd to 3rd place by April 2024, with sales peaking in January before declining. This dynamic suggests that while Stigma Grow remains the top contender, the gap between it and its competitors, especially Glacial Gold, is narrowing, highlighting a competitive market where brand positioning and sales performance are in constant flux.

Stigma Grow market ranking for AB Capsules

Stigma Grow

Notable Products

In April 2024, Stigma Grow's top-selling product was the Indica RSO Capsules 25-Pack (250mg), maintaining its number one rank from previous months with sales figures reaching 6963 units. Following closely, the Phoenix Tears RSO (1g) continued its steady performance as the second highest-selling product, showcasing a notable increase in sales to 3303 units from March. The CBD Softgels 15-Pack (750mg CBD) also held its ground, ranking third consistently across the board. A new entry into the top products list was the Baja Banana Infused Pre-Roll 3-Pack (1.5g), which debuted at fourth place in April with 197 units sold, indicating a growing interest in the Pre-Roll category. Lastly, the Phoenix Tears Honey Oil (1g) experienced a slight drop, moving from the fourth position to fifth, reflecting a dynamic shift in consumer preferences within the Concentrates category.

Product Rank
Category
Jan-2024
Feb-2024
Mar-2024
Apr-2024
Indica RSO Capsules 25-Pack (250mg)
Capsules
1
1
1
1
Phoenix Tears RSO (1g)
Concentrates
2
2
2
2
CBD Softgels 15-Pack (750mg CBD)
Capsules
3
3
3
3
Baja Banana Infused Pre-Roll 3-Pack (1.5g)
Pre-Roll
>5
>5
>5
4
Phoenix Tears Honey Oil (1g)
Concentrates
4
4
4
5
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Research the top cannabis brands across markets in the US and Canada.
Header image
User rating
start Today
Connect to Headset

Get Cannabis Market Data